Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage?

European Journal of Ophthalmology

Volumn 19, Issue 4, 2009, Pages 618-621

  Romano, Mario R ^a   Gibran, S K ^b   Marticorena, Joaquin ^a   Wong, David ^a,c   Heimann, Henrich ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Intraoperative bevacizumab injection; Proliferative diabetic retinopathy; Vitreous hemorrhage

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETIC RETINOPATHY; EYE SYNECHIA; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PEROPERATIVE CARE; PRIORITY JOURNAL; PSEUDOPHAKIA; RECURRENT DISEASE; SLIT LAMP; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CATARACT; DIABETIC RETINOPATHY; FEMALE; HUMANS; INJECTIONS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECURRENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY; VITREOUS HEMORRHAGE;

EID: 70349473580     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900416     Document Type: Article

References (14)

1. Novak MA, Rice TA, Michels RG, Auer C. Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology 1984; 91: 1485-9.
2. Oyakawa RT, Schachat AP, Michels RG, Rice TA. Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology 1983; 90: 522-30.
3. Sima P, Zoran T. Long-term results of vitreous surgery for proliferative diabetic retinopathy. Doc Ophthalmol 1994; 87: 223-32.
4. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113: 1695-705.
5. Landers MB, Perraki AD. Management of post-vitrectomy persistent vitreous hemorrhage in pseudophakic eyes. Am J Ophthalmol 2003; 136: 989-93.
6. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006; 26: 275-8.
7. Rizzo S, Genovesi-Ebert F, Di Bartolo E, Vento A, Miniaci S, Williams G. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Graefes Arch Clin Exp Ophthalmol 2008; 246: 837-42.
8. West JF, Gregor ZJ. Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol 2000; 84: 822-5.
9. Bodanowitz S, Kir N, Hesse L. Silicone oil for recurrent vitreous hemorrhage in previously vitrectomized diabetic eyes. Ophthalmologica 1997; 211: 219-22.
10. Faghihi H, Taheri A, Farahvash MS, Esfahani MR, Rajabi MT. Intravitreal Triamcinolone acetonide at the end of the vitrectomy for diabetic vitreous haemorrhage: a randomized, clinical trial. Retina 2008; 28: 1241-6.
11. Yang CM, Yeh PT, Yang CH. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy. Ophthalmology 2007; 114: 710-5.
12. Yang CM, Yeh PT, Yang CH, Chen MS. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol 2008; 146: 211-7.
13. Comer GM, Ciulla TA. Pharmacotherapy for diabetic retinopathy. Curr Opin Ophthalmol 2004; 15: 508-18.
14. Warner TD. Relationships between the endothelin and nitric oxide pathways. Clin Exp Pharmacol Physiol 1999; 26: 247-52.